CSI Market
Sign In | Register

Portage Biotech Inc (PRTG) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PRTG Annual Balance Sheets →
A period-by-period view of the balance sheet from Portage Biotech Inc to Mar 31 2024 helps clarify how Mar 31 2025's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2025)
0 0 0 (Mar 31 2024)
Assets
Cash And Cash Equivalents1.67
Cash & Short-term Investments1.00
Accounts receivable0.00
Other Current Assets0.56
Total Current Assets2.23
Goodwill net0.00
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.00
Total Assets2.23
Liabilities
Accounts Payable0.00
Other Liabilities, Current1.10
Total Current Liabilities1.10
Total Long-term Debt0.00
Other liabilities, Noncurrent1.95
Total Liabilities3.05
Stockholders' Equity
Other Equity-0.82
Common Stockholder's Equity-0.82
Total Stockholder's Equity-0.82
Liabilities & Stockholder's Equity2.23
4 historic quarters locked

Sign in to unlock the full Portage Biotech Inc balance sheet history.

Sign In Create Free Account

About Portage Biotech Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20250331)
  • Filed with the SEC: July 25, 2025
  • Source: f20f_071425.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001171843-25-004718

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.